Transactivation of Src, PDGF receptor, and Akt is involved in IL-1beta-induced ICAM-1 expression in A549 cells

Chih-Chung Lin1, Chiang-Wen Lee, Tzu-Hua Chu

  • 1Department of Anesthetics, Chang Gung University, Kwei-San, Tao-Yuan, Taiwan.

Insights

Interleukin-1beta (IL-1beta) induces ICAM-1 expression via Src, PDGFR, and PI3K/Akt pathways, involving p300 transcriptional activity and histone acetylation. This pathway enhances neutrophil adhesion, which is inhibited by blocking these signaling molecules.

Area of Science:

  • Cellular and Molecular Biology
  • Immunology
  • Biochemistry

Background:

  • Interleukin-1beta (IL-1beta) is a key inflammatory cytokine.
  • IL-1beta induces ICAM-1 expression, crucial for immune cell adhesion.
  • Previous studies implicated MAPKs and NF-kappaB in IL-1beta-induced ICAM-1 expression.

Purpose of the Study:

  • To investigate the role of non-receptor tyrosine kinase (Src), PDGF receptors (PDGFRs), and PI3K/Akt pathways in IL-1beta-induced ICAM-1 expression in A549 cells.
  • To elucidate the downstream molecular mechanisms, including p300 activity and histone acetylation, involved in this process.
  • To assess the functional consequence of ICAM-1 upregulation on neutrophil adhesion.

Main Methods:

  • Reporter gene assays, Western blotting, and RT-PCR to analyze ICAM-1 expression and promoter activity.
  • Transfection with dominant-negative plasmids for Src, p85, and Akt.
  • Chromatin immunoprecipitation (ChIP) assays to determine protein-DNA interactions and histone modifications.
  • Inhibition studies using specific pathway inhibitors (PP1, AG1296, LY294002, wortmannin, SH-5, curcumin, helenalin).

Main Results:

  • Inhibitors of Src, PDGFR, PI3-K, and Akt attenuated IL-1beta-induced ICAM-1 promoter activity.
  • Dominant-negative Src, p85, and Akt significantly reduced IL-1beta-induced ICAM-1 expression.
  • IL-1beta-stimulated phosphorylation of Src, PDGFR, and Akt was abrogated by pathway inhibitors.
  • p300 inhibition blocked ICAM-1 expression, and p300 association with the ICAM-1 promoter correlated with histone H4 acetylation.
  • LY294002 inhibited the association of p300 and histone-H4 with the ICAM-1 promoter.
  • Upregulated ICAM-1 enhanced neutrophil adhesion, which was reversed by pathway inhibitors.

Conclusions:

  • Akt phosphorylation, mediated by Src/PDGFR transactivation, promotes IL-1beta-induced ICAM-1 expression in A549 cells.
  • The Src/PDGFR/PI3K/Akt pathway regulates ICAM-1 expression through p300 transcriptional coactivator activity and histone H4 acetylation.
  • Targeting these signaling pathways can inhibit IL-1beta-induced ICAM-1 expression and subsequent neutrophil adhesion.

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...